HIV-1 TAT Clade-A Recombinant, HIV-1 TAT Clade-A, 10ug

CAT No.BT-HIV-105

HIV-1 TAT Clade-A Recombinant, HIV-1 TAT Clade-A, 10ug

---

Applications
Western Blotting, SDS Page.
Reacts with Mouse anti-Tat antibodies.

Description
HIV-1 TAT Clade-A Recombinant produced in E.coli is a single, non-glycosylated, polypeptide chain having the Accession number: AY194047.1.

Formulation
Lyophilized with 10% glycerol.

Sterile Filtered White lyophilized (freeze-dried) powder.

Purity
Greater than 90.0% as determined by SDS-PAGE.

Solubility
It is recommended to reconstitute the lyophilized HIV-1 TAT in sterile 18M¦¸-cm H2O not less than 100ug/ml, which can then be further diluted to other aqueous solutions.

Source
Escherichia Coli.

Stability
Lyophilized HIV-1 TAT although stable at room temperature for 1 week, should be stored desiccated below -18¡ãC. Upon reconstitution HIV-1 TAT should be stored at 4¡ãC between 2-7 days and for future use below -18¡ãC. For long-term storage it is recommended to add a carrier protein (0.1% HSA or BSA).
Please prevent freeze-thaw cycles.

Usage
TSZGENE's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.